A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo

Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
12/1997
12/24/1997	CN1168636A Liposomal agents
12/24/1997	CA2258631A1 Rhenium radioactive catheter
12/24/1997	CA2258526A1 Tie-2 receptor ligands (tie ligand-3; tie ligand-4) and their uses
12/23/1997	US5700907 Nucleotide sequences coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses
12/23/1997	US5700446 Neurological disease testing
12/23/1997	US5700444 Metallopeptide for drug delivery, diagnosis, treating infections, inflammations, diseases
12/18/1997	WO1997047329A2 Radiopharmaceutical compositions capable of localizing at sites of thrombus
12/18/1997	WO1997047328A1 Synthesis of ferrocenyl phenyltropane analogs and their radio-transformation to technetium neuroprobes for mapping monoamine reuptake sites
12/18/1997	CA2257856A1 Radiopharmaceutical compositions capable of localizing at sites of thrombus
12/17/1997	EP0812356A1 Prostate-specific membrane antigen and uses thereof
12/17/1997	EP0652896B1 Peptide compounds
12/17/1997	CN2270506Y Gastrointestinal tract radiography capsule and pill
12/17/1997	CN1167639A Magnetic resonance contrast medium for gastrointestinal tract
12/17/1997	CN1036717C Polyazamacrocyclic compounds for complexation of metal ions
12/16/1997	US5698405 Coupling immunogenic agent with a carbohydrate polymer
12/16/1997	US5698178 Binding a multidrug transporter protein and an antigen associated with a tumor or infectious agent
12/16/1997	US5697902 Treating patient with antibody or antibody fragment conjugated to cytotoxic agent
12/16/1997	CA2011745C Dopamine receptor ligands and imaging agents
12/11/1997	WO1997046558A1 Pyrrolo[2,3-b]pyridine derivatives, useful as radiolabelled d4 receptor ligands
12/11/1997	WO1997046268A1 Implantable medical device
12/11/1997	WO1997046098A1 Cluster clearing agents
12/11/1997	WO1997038730A3 Radioactivity local delivery system
12/11/1997	CA2257363A1 Cluster clearing agents
12/11/1997	CA2256351A1 Pyrrolo[2,3-b]pyridine derivatives, useful as radiolabelled d4 receptor ligands
12/10/1997	EP0810989A1 Novelly substituted dtpa derivatives, metal complexes thereof, pharmaceuticals containing these complexes, diagnostic and therapeutic uses thereof and methods for preparing the complexes and pharmaceuticals
12/10/1997	EP0810883A2 Individual medicament dosing conjugate
12/10/1997	EP0810878A2 Rna photocleavage using texaphyrins
12/10/1997	EP0810855A1 Polyalkylene block copolymers as surface modifiers for nanoparticles
12/10/1997	EP0570575B1 Bicycloazamacrocyclophosphonic acid, conjugates, contrast agents and preparation
12/10/1997	CN1167505A Tie-2 ligands, methods of making and uses thereof
12/10/1997	CN1167444A Use of metal complexes as liver and gall bladder radiodiagnosis agent in CT scanning
12/10/1997	CN1166989A Radio-immunity treatment agent of anti human hepatic cancer monoclone antibody HAb18
12/10/1997	CN1166988A Radio-immunity diagnosis agent of anti human hepatic cancer monoclone antibody HAb18
12/09/1997	US5696239 Conjugates possessing ortho ligating functionality and complexes thereof
12/09/1997	US5696087 Administering a polypeptide
12/09/1997	US5695737 Dimeric DTPA derivatives, their metal complexes and pharmaceutical agents containing these complexes
12/09/1997	CA2058935C Pharmaceutical compositions and method for treatment using alzheimer's amyloid peptides
12/04/1997	WO1997045556A1 Methods and compositions for determining the tumor suppressor status of cells
12/04/1997	WO1997026919A3 Method of imaging amyloid deposits
12/04/1997	CA2247995A1 Methods and compositions for determining the tumor suppressor status of cells
12/03/1997	EP0810435A2 Detectable molecules, method of preparation and use
12/03/1997	EP0809698A1 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF TUMOR GENE Int6
12/03/1997	EP0809518A1 A METHOD FOR THE IN VITRO MEASUREMENT OF THE ELIMINATION OF LABELLED hCG IN HUMANS, AN AGENT TO BE USED IN THE METHOD AS WELL AS THE USE THEREOF FOR THE ESTABLISHMENT OF THE ELIMINATION OF PATHO-PHYSIOLOGICALLY PRODUCED hCG OR FOR THE ESTABLISHMENT OF ORGAN FUNCTION
12/03/1997	EP0627939B1 Conjugates of biotin and deferoxamine for radioimmunoimaging and radioimmunotherapy
12/02/1997	US5693763 Antibodies to human carcinoma antigen
12/02/1997	US5693324 Tris(isonitrile) copper(I) sulfates for preparing radionuclide complexes
12/02/1997	US5693310 Amide complexes
11/1997
11/27/1997	WO1997044461A2 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
11/27/1997	WO1997044460A1 Modulators of tissue regeneration
11/27/1997	WO1997044110A1 TECHNETIUM-99m GENERATOR SYSTEM
11/27/1997	CA2496906A1 Ret ligand (retl) for stimulating neural and renal growth
11/26/1997	EP0466816B1 Method for enhancing transmembrane transport of exogenous molecules
11/25/1997	US5691358 4-amino-n-(4-methyl-4-piperidinyl)-2-methoxybenzamides
11/25/1997	US5691311 Methods for coating invasive devices with inhibitors of thrombin
11/25/1997	US5691306 Protein secretion
11/25/1997	US5690907 Ultrasonic and magnetic resonance imaging; x-rays, tomography
11/25/1997	US5690906 Dopamine D-3 and serotonin (5-HT1A) receptor ligands and imaging agents
11/25/1997	US5690905 Peptide-metal ion pharmaceutical labeling method
11/25/1997	US5690904 Diagnostic radiopharmaceutical compounds (That)
11/25/1997	US5690903 Loading and conjugating cavity biostructures
11/20/1997	WO1997043285A1 Tropane derivatives useable in particular for in vivo detection of dopamine transporters
11/20/1997	WO1997043271A1 Alkylaminobenzothiazole and -benzoxazole derivatives
11/20/1997	CA2254089A1 Tropane derivatives useable in particular for in vivo detection of dopamine transporters
11/19/1997	EP0807683A2 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
11/19/1997	EP0806969A2 Liposomes containing contrast media for blood pool imaging
11/19/1997	EP0806968A2 Diagnostic imaging contrast agents with extended blood retention
11/19/1997	CN1165167A Method for making medicated chalk
11/18/1997	US5688922 Chemical intermediates for glycyrrhetinic acid derivatives, selectin ligands, inhibitors of leukotriene biosynthesis
11/18/1997	US5688814 4-amino-N-(4-methyl-4-piperidinyl)-2-methoxybenzamides
11/18/1997	US5688657 Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor
11/18/1997	US5688489 Non-receptor mediated imaging agents
11/18/1997	US5688488 Composition and method for tumor imaging
11/18/1997	US5688487 Diagnostic imaging methods using rhenium and technetium complexes containing a hypoxia-localizing moiety
11/18/1997	US5688486 Use of fullerenes in diagnostic and/or therapeutic agents
11/18/1997	US5688485 Radiolabelled complexes of ester-substituted diaminethiols
11/18/1997	CA1339546C Recombinant hybrid immunogloblin molecules an method of use
11/13/1997	WO1997042217A1 Radiolabeled fusion toxins for cancer therapy
11/13/1997	WO1997041898A1 Targeted combination immunotherapy of cancer
11/13/1997	WO1997041886A1 Stimulation of host defence mechanisms against tumors
11/13/1997	WO1997041883A1 Stimulation of host defense mechanisms against viral challenges
11/13/1997	WO1997041856A1 ORGANOMETALLIC LIGANDS FOR THE LOCALIZATION AND QUANTIFICATION OF AMYLOID IN VIVO AND $i(IN VITRO)
11/13/1997	WO1997025074A3 Cellular and serum protein anchors for diagnostic imaging
11/13/1997	CA2253908A1 Stimulation of host defence mechanisms against tumors
11/13/1997	CA2253904A1 Targeted combination immunotherapy of cancer
11/13/1997	CA2253902A1 Stimulation of host defense mechanisms against viral challenges
11/12/1997	EP0806670A2 Use of an anticoagulant as a diagnostic agent
11/12/1997	EP0805703A1 Balloon catheter used to prevent re-stenosis after angioplasty and process for producing a balloon catheter
11/12/1997	EP0805687A1 Recombinant human alpha-fetoprotein and uses thereof
11/12/1997	EP0649532B1 Photoactivation of proteins for conjugation purposes
11/11/1997	US5686578 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
11/11/1997	US5686410 Polypeptide derivatives
11/11/1997	US5686071 Polymer affinity system for the delivery of cytotoxic material and other compounds to sites of disease
11/11/1997	US5686059 Cartilage matrix protein and methods for use
11/11/1997	US5686058 Radiolabelled nucleotide formulations stored in an unfrozen state
11/06/1997	WO1997041154A1 Eosinophil eotaxin receptor
11/06/1997	WO1997040859A1 Bridge-substituted tropanes and uses
11/06/1997	WO1997040857A1 Drug delivery using terminal complement components
11/06/1997	WO1997040856A1 Diagnostic composition
11/06/1997	CA2252850A1 Eosinophil eotaxin receptor
11/05/1997	EP0804932A2 Contrast media for diagnostic imaging comprising gas filled microspeures

1 ... 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 ... 243